MEPs from the Public Health Committee agreed on a proposal to oblige pharmaceutical companies and academic researchers upload the results of all their European clinical trials to a publicly accessible database. The new legislation aims to encourage research whilst protecting patients' rights.
As rapporteur Glenis Willmott (S&D, UK) said: "For too long, unflattering studies on new medicines have gone undisclosed. Around half of all trials are never published, usually those with negative or...
This story is part of New Europe's Premium content.
|To Read the Full Story, Subscribe or Sign In from the ↑ Top of the Page ↑|